Status:
COMPLETED
Meditation Versus Education for Improving Depression in Chronic Pain, a Randomized Controlled Trial
Lead Sponsor:
Mount Sinai Hospital, Canada
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Lunenfeld Tanenbaum Research Institute
Conditions:
Chronic Pain
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study two possible treatment options available for depression and chronic pain will be explored. Both of these treatments will be offered through online group video calls, which could translat...
Detailed Description
OBJECTIVES To determine whether depressive symptoms, pain severity, function, quality of life, as well as opioid use can be affected by a lifestyle intervention program in depression and chronic pain....
Eligibility Criteria
Inclusion
- ≥18 years of age;
- 2\. Significant depressive symptomology (PHQ-9 score ≥10);
- Chronic pain (pain ≥3 months duration in any body region, by self-report);
- Be willing and able to attend all 4 training sessions of SSM/HEP and 75% of follow-up sessions;
- Understanding of English language (spoken and written);
- Able to sit for 20-25 minutes without significant discomfort;
- Regular access to internet and ability to participate in video calls
Exclusion
- Other major psychiatric conditions including substance use disorder, psychosis and cognitive impairment as excluded by the Mini-International Neuropsychiatric Interview (MINI) Screening and Standard tool; severe depression (PHQ-9 ≥20) and risk of imminent suicide as per MINI and/or PHQ-9;
- Non-correctable, clinically significant sensory impairment;
- Acutely unstable medical illnesses, including delirium or acute cerebrovascular or cardiovascular events within the last 6 months;
- A terminal medical diagnosis with prognosis of less than 12 months;
- Currently practising any form of mind-body intervention;
- Inability to provide informed consent
Key Trial Info
Start Date :
October 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT04039568
Start Date
October 30 2019
End Date
March 31 2023
Last Update
October 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bridgepoint Collaboratory, Sinai Health
Toronto, Ontario, Canada, M4M 2B5